Table 3.

Multivariable association of an episode of AKI and change (fold increase) in level of urine protein-to-creatinine ratio overall and analyses that exclude receipt of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker or systolic BP level

Comparisons	Full Model (Shown in Supplemental Table 1)		Model Excluding Receipt of ACE-I/ARB		Model Excluding Systolic BP Level
	Relative Risk (95% CI)	P Value	Relative Risk (95% CI)	P Value	Relative Risk (95% CI)	P Value
AKI between study visits (versus no AKI)	1.09 (1.02 to 1.16)	0.01	1.09 (1.02 to 1.17)	0.01	1.07 (1.00 to 1.14)	0.04

ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; 95% CI, 95% confidence interval.